Get caught up on the latest technology and startup news from the past week. Here are the most popular stories on GeekWire for the week of Dec. 19, 2021.
Sign up to receive these updates every Sunday in your inbox by subscribing to our GeekWire Weekly email newsletter.
Most popular stories on GeekWire
Bill Gates is taking the action that many people are perhaps dreading themselves — canceling most of his holiday plans in the wake of the rapid spread of the COVID-19 variant Omicron. … Read More

A settlement between Amazon and the National Labor Relations Board will end a company policy that prevented workers from remaining in a non-working area of an Amazon facility for more than 15 minutes beyond their shifts. … Read More

Within the span of an hour last weekend, I went from holiday shopping at several small businesses in Seattle’s Capitol Hill neighborhood to getting my COVID-19 booster shot at Amazon’s headquarters downtown. … Read More

The Tampa Bay Buccaneers weren’t the only ones to get battered and beaten during a “Sunday Night Football” game this week. … Read More

The 110 Tacoma, Wash., families chosen to participate in a guaranteed income program received their first $500 check this month, according to MyNorthwest. … Read More

Uplevel makes software tools to help engineering teams better measure how developers use their time and how they could best avoid burning out. … Read More

Alexandria Real Equities, a life sciences real estate developer, has bought a 5.2-acre property in Bellevue, Wash., for $77.5 million. … Read More

The launch of NASA’s $10 billion James Webb Space Telescope from French Guiana could mark a triumph in a tale that thousands of astronomers have been following for a generation. … Read More

Rec Room, the Seattle-based development studio behind the fast-growing VR application Rec Room, has raised $145 million in new funding, bringing its current valuation to $3.5 billion. … Read More

Washington state public health officials are urging people to get vaccinated and boosted against COVID-19. … Read More